Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pizzuti

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Medical Oncology|August 28, 2019
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world settingAnna Di Benedetto, Cristiana Ercolani, Laura Pizzuti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung AdenocarcinomaFrauke Goeman, Francesca De Nicola, Stefano Scalera, et al.
Vaccines|May 2, 2020
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with ImmunotherapyAndrea Botticelli, Alessio Cirillo, Simone Scagnoli, et al.
Sexual Medicine Reviews|April 19, 2023
Sexual dysfunctions in breast cancer patients: evidence in contextRiccardo Vizza, Elisabetta Maria Capomolla, Livia Tosetto, et al.
Journal of Cellular Physiology|May 18, 2016
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT TrialLaura Pizzuti, Maddalena Barba, Diana Giannarelli, et al.
Oncoimmunology|July 30, 2016
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironmentSimonetta Buglioni, Patrizia Vici, Domenico Sergi, et al.
Journal of Cellular Physiology|October 10, 2015
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With EribulinMaddalena Barba, Laura Pizzuti, Isabella Sperduti, et al.
Plos One|March 2, 2016
DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory AnalysisPatrizia Vici, Simonetta Buglioni, Domenico Sergi, et al.
Breast (Edinburgh, Scotland)|August 23, 2022
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY studyGiulia Mentrasti, Luca Cantini, Patrizia Vici, et al.
Oncotarget|November 7, 2015
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysisPatrizia Vici, Anna Di Benedetto, Cristiana Ercolani, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|August 28, 2019
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world settingAnna Di Benedetto, Cristiana Ercolani, Laura Pizzuti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 20, 2019
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung AdenocarcinomaFrauke Goeman, Francesca De Nicola, Stefano Scalera, et al.
Vaccines|May 2, 2020
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with ImmunotherapyAndrea Botticelli, Alessio Cirillo, Simone Scagnoli, et al.
Sexual Medicine Reviews|April 19, 2023
Sexual dysfunctions in breast cancer patients: evidence in contextRiccardo Vizza, Elisabetta Maria Capomolla, Livia Tosetto, et al.
Journal of Cellular Physiology|May 18, 2016
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT TrialLaura Pizzuti, Maddalena Barba, Diana Giannarelli, et al.
Oncoimmunology|July 30, 2016
Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironmentSimonetta Buglioni, Patrizia Vici, Domenico Sergi, et al.
Journal of Cellular Physiology|October 10, 2015
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With EribulinMaddalena Barba, Laura Pizzuti, Isabella Sperduti, et al.
Plos One|March 2, 2016
DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory AnalysisPatrizia Vici, Simonetta Buglioni, Domenico Sergi, et al.
Breast (Edinburgh, Scotland)|August 23, 2022
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY studyGiulia Mentrasti, Luca Cantini, Patrizia Vici, et al.
Oncotarget|November 7, 2015
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysisPatrizia Vici, Anna Di Benedetto, Cristiana Ercolani, et al.
Pageof 12